| INNOVENT BIOLOGICS INC. |
| China |
| Gesundheit |
| KYG4818G1010 / A2N7N8 |
| 6IB (Frankfurt) |
| FRA:6IB, ETR:6IB, 6IB:GR |
| - |
| http://cn.innoventbio.com.. |
|
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmaceutical and biotechnology company based in China, ..
>Volltext.. |
| 16472.59 Mio. EUR |
| 14591.07 Mio. EUR |
| 1580.11 Mio. EUR |
| - |
| 97.51 Mio. EUR |
| 0.06 EUR |
| 350.11 Mio. EUR |
| 2156.59 Mio. EUR |
| - |
| 2.17 |
| 21.91% |
| - |
| - |
| - |
| - |
| - |
| INNOVENT BIOLOGICS, INNOVENT BIO |
| 31.03.26 |
|